Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed1
Other3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04938115Not ApplicableCompleted
Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia
Leukemia, T Cell
PrincipalinvestigatorStart date: 2021-05-10
NCT04928105Not ApplicableUnknown
Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma
Lymphoma, T-Cell
PrincipalinvestigatorStart date: 2021-01-27

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hebei Yanda Ludaopei Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04938115Not ApplicablePrincipalInvestigator

Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia

Leukemia, T Cell
Completed
NCT04928105Not ApplicablePrincipalInvestigator

Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma

Lymphoma, T-Cell
Unknown
NCT04796441Not ApplicablePrincipalInvestigator

Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation

AML
Unknown
NCT04792593Not ApplicablePrincipalInvestigator

Senl-h19 CAR-T Cell Injection in the Treatment of Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

B-ALL
Unknown

All 4 trials loaded